Patents by Inventor J. Erik Johnson

J. Erik Johnson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20090175900
    Abstract: A method of producing propagation-defective Vesicular Stomatitis Virus (VSV) in a cell culture is provided. The method involves introducing a plasmid vector encoding an optimized VSV G gene into a cell; expressing VSV G protein from the optimized VSV G gene; and introducing a propagation-defective VSV into the cell expressing the VSV G protein encoded by the optimized VSV G gene. The method further includes growing the cells in culture; and recovering the propagation-defective VSV from the culture.
    Type: Application
    Filed: December 16, 2008
    Publication date: July 9, 2009
    Applicant: Wyeth
    Inventors: Christopher L. Parks, Susan E. Witko, Maninder K. Sidhu, J. Erik Johnson, Roger Michael Hendry
  • Publication number: 20090162321
    Abstract: A method of producing propagation-defective Vesicular Stomatitis Virus (VSV) is provided. The method involves providing a cell that includes an optimized VSV G gene, wherein expression of VSV G protein from the optimized VSV G gene is inducible; and inducing the cell to express VSV G protein from the optimized VSV G gene. The method also involves infecting the induced cell with an attenuated VSV; growing the infected cells in culture; and recovering attenuated VSV from the culture.
    Type: Application
    Filed: December 16, 2008
    Publication date: June 25, 2009
    Applicant: Wyeth
    Inventors: Christopher L. Parks, Susan E. Witko, Maninder K. Sidhu, J. Erik Johnson, Roger Michael Hendry
  • Patent number: 7361496
    Abstract: This invention relates to a method for recombinantly producing, via rescue of mumps virus, a nonsegmented, negative-sense, single-stranded RNA virus, and immunogenic compositions formed therefrom. Additional embodiments relate to methods of producing the mumps virus as an attenuated and/or infectious virus. The recombinant viruses are prepared from cDNA clones, and, accordingly, viruses having defined changes, including nucleotide/polynucleotide deletions, insertions, substitutions and re-arrangements, in the place of the genome are obtained.
    Type: Grant
    Filed: August 2, 2000
    Date of Patent: April 22, 2008
    Assignee: Wyeth
    Inventors: David K. Clarke, J. Erik Johnson, Mohinderjit S. Sidhu, Stephen A. Udem